nach oben

Intensive Care Medicine

Erschienen in:

27.11.2019 | Less is more in Intensive Care

Less empiric broad-spectrum antibiotics is more in the ICU

verfasst von: Jose Mauro da Fonseca Pestana Ribeiro, Marcelo Park

Erschienen in: Intensive Care Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Antibiotics are administered in approximately 71% of patients who are admitted to the intensive care unit (ICU) and have helped to save millions of lives [1]. However, up to half of all antibiotic prescriptions may be unnecessary [2]. Antibiotic overuse has contributed to alarmingly high levels of global antibiotic resistance, which is increasing at a rate faster than that at which novel antibiotics are produced. Therefore, finding a fine balance between the appropriate use and avoidance of unnecessary administration is crucial to prevent the renaissance of a new world without antibiotics [2]. …

Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323–2329CrossRef

Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D et al (2012) Ready for a world without antibiotics? The Pensières antibiotic resistance call to action. Antimicrob Resist Infect Control. 1(1):11CrossRef

Evans GM, Gaisford W (1938) Treatment of pneumonia with 2-(p-aminobenzenesulphonamido) pyridine. Lancet 232(5992):14–19CrossRef

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43(3):304–377CrossRef

Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196(7):856–863CrossRef

Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP et al (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42(8):1749–1755CrossRef

Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR et al (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 6(1):40–50CrossRef

Corona A, Bertolini G, Lipman J, Wilson AP, Singer M (2010) Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). J Antimicrob Chemother 65(6):1276–1285CrossRef

Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE (2015) The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med 43(9):1907–1915CrossRef

10.

Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD et al (2012) Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis. 12(10):774–780CrossRef

11.

Contou D, Roux D, Jochmans S, Coudroy R, Guérot E, Grimaldi D et al (2016) Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study. Crit Care 20(1):360CrossRef

12.

Kahn JM, Davis BS, Yabes JG, Chang CH, Chong DH, Hershey TB et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240–250CrossRef

13.

Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 13(9):785–796CrossRef

14.

Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJL, Gniadkowski M et al (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 14(1):31–39CrossRef

15.

Abdallah M, Badawi M, Alzaagi I, Issa KN, Rasheed A, Alharthy A (2019) Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit. J Chemother. 31:261CrossRef

16.

Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanèse J, Jaber S et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40(10):1399–1408CrossRef

17.

Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF et al (2005) Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 366(9482):308–313CrossRef

18.

Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A et al (2012) Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 80(1):62–73CrossRef

19.

Morris AM, Bai A, Burry L, Dresser LD, Ferguson ND, Lapinsky SE et al (2019) Long-term effects of phased implementation of antimicrobial stewardship in academic ICUs: 2007–2015. Crit Care Med 47(2):159–166CrossRef

20.

Lam TJGM, Jansen J, Wessels RJ (2017) The RESET mindset model applied on decreasing antibiotic usage in dairy cattle in the Netherlands. Ir Vet J. 70:5CrossRef

Titel: Less empiric broad-spectrum antibiotics is more in the ICU
verfasst von: Jose Mauro da Fonseca Pestana Ribeiro
Marcelo Park
Publikationsdatum: 27.11.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 4/2020
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-019-05863-z

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Less empiric broad-spectrum antibiotics is more in the ICU

Excerpt

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists

Intensive care during the coronavirus epidemic

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline

Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

Understanding gender disparities in outcomes after sepsis

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS